Tremelimumab

ATC L01FX20 · 10 markets · 16 records

Tremelimumab 10 markets · 16 records Forms

AU 4 records · 4 strengths

300 mg/15 mLinjectionIMJUDO also in US·GB
300 mginjectionIMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial also in ES unknown
25 mginjectionIMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial unknown

Records without a stated strength · 1 IMJUDO

US 2 records · 2 strengths

300 mg/15 mLinjectionIMJUDO also in AU·GB
25 mg/1.25 mLinjectionIMJUDO

HK 2 records · 1 strengths

Records without a stated strength · 1 IMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 25MG/1.25ML

GB 1 records · 1 strengths

300 mg/15 mLinjectionImjudo 300mg/15ml concentrate for solution for infusion vials also in AU·US

CA 1 records · 1 strengths

20 mgliquidIMJUDO

SG 1 records · 1 strengths

20 mg/mLinjectionIMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

ES 1 records · 1 strengths

300 mginjectionIMJUDO also in AU

MX 1 records · 1 strengths

Records without a stated strength · 1 IMJUDO

TW 1 records · 1 strengths

Records without a stated strength · 1 IMJUDO Injection 20mg/ml、抑佳妥注射劑

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 IMJUDO

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.